Menu
Now in its 23rd year, Medlab Middle East has garnered a world-leading reputation as a forum where major advances in laboratory medicine take shape, progress and – perhaps most importantly of all – deliver.
Recently, this impact has been particularly evident in the area of sustainable solutions. The 2024 edition promises to be another landmark moment in the sector’s trajectory.
It will also be one of Medlab’s biggest editions to date. For 2024, the event has massively increased its footprint, in order to accommodate three times the number of exhibitors as participated previously. Given that the 2023 show generated US$523.9m of business, the commercial value of this year’s show to the industry is therefore expected to be significant. These exhibitors will be arranged across eight dedicated product categories: disposables; healthcare and general services; imaging; infrastructure; IT; laboratory; medical equipment; and pharma/nutrition.
Alongside the trade show component, there will also be another edition of the Medlab Middle East Congress, offering 12 CME-accredited in-person conferences and hosting a series of world-class speakers and professionals. Topics featured at the Congress will include laboratory management; haematology; clinical chemistry; immunology and more.
